The Valley Desk

Clinical trial reportJournal of medicinal chemistryPublished

Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Clinical trial report
Venue
Journal of medicinal chemistry
Published
Subject terms
Animals; Dogs; Humans; Mice; Rats; Antineoplastic Agents; Administration, Oral; Structure-Activity Relationship; Biological Availability; Dose-Response Relationship, Drug; Proto-Oncogene Proteins p21(ras); Drug Discovery
PubMed ID
38924388
Added to directory
Source checked

Report a correction or request removal